Structure of Doxorubicin HCl CAS 25316 40 9 - Doxorubicin HCl CAS 25316-40-9 Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions and Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

25316-40-9

Name

Dox­oru­bicin HCl

Syn­onyms

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxyhexopyranoside hydrochlo­ride (1:1) [ACD/IUPAC Name] (1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl-3-amino-2,3,6-tridesoxyhexopyranosidhydrochlorid (1:1) [Ger­man] [ACD/IUPAC Name] (1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside hydrochlo­ride (1:1) 3-Amino-2,3,6-tridésoxyhexopyranoside de (1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacétyl)-10-méthoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tétracényle, chlorhy­drate (1:1) [French] [ACD/IUPAC Name] 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxyhexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-, hydrochlo­ride (1:1) [ACD/​Index Name] (7S,9S)-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochlo­ride (8S,10S)-10-((3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochlo­ride (8S-cis)-10-((3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochlo­ride [25316-40-9] 23214-92-8 [RN] 25316-40-9 [RN] 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-α-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochlo­ride, (8S-cis)- 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochlo­ride (8S-cis)- 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochlo­ride 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochlo­ride, (8S-cis)- 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochlo­ride, (8S-cis)- 56390-09-1 [RN] ADM hydrochlo­ride ADRIACIN Adri­amycin [Wiki] Adri­amycin PFS Adri­amycin RDF Adri­amycin, hydrochlo­ride Adriblastin Adriblasti­na [Trade name] Adriblasti­na RD Dox­oru­bicin HCl Dox­oru­bicin hydrochlo­ride [JAN] Epiru­bicin hydrochlo­ride [JAN] [JP15] [USAN] Hydrox­y­daunoru­bicin hydrochlo­ride Lipo­dox MFCD00077757 [MDL num­ber] Rubex

Mol­e­c­u­lar Structure

Structure of Doxorubicin HCl CAS 25316 40 9 - Doxorubicin HCl CAS 25316-40-9

Struc­­ture-of-Dox­oru­bicin-HCl-CAS-25316-40-9

SMILES

CC1C(C(CC(O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3O)C(=O)c5cccc(c5C4=O)OC)O)(C(=O)CO)O)N)O.Cl

Std­InChI

InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3 ;1H/t10?,13?,15-,17?,22?,27-;/m0./s1

Std­InChIKey

MWWSFMD­­VAYGXBV-FGB­JB­­KNOSA-N

Mol­e­c­u­lar Formula

C27H29NO11.HCl

Mol­e­c­u­lar Weight

579.99

EINECS

246-818-3

Prop­er­ties

Appear­ance

Orange red pow­der

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Dox­oru­bicin HCl CAS 25316-40-9

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HNMR/HPLC

Puri­ty

98%-102%

Spe­cif­ic Opti­cal Rotation

+31.0-+35.0°

Heavy Met­als

0.001%max

Water

4.0%max

Residue on Ignition

0.1%max

Total of ace­tone and alcohol

2.5%max

Sin­gle Impurity

0.5%max

Total Impu­ri­ties

2.0%max

PH

4.5-5.5

Stor­age

Pack­ing in tight con­tain­ers, pro­tect­ed from light, at 2℃~8℃.

Appli­ca­tion

Often as antibi­otics, pri­mar­i­ly for anti-tumor drugs.

Links

This prod­uct is devel­oped by our RandD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​d​o​x​o​r​u​b​i​c​i​n​-​h​c​l​-​c​a​s​-​2​5​3​1​6​-​4​0​-9/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the house.




    andD pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.